Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Nemolizumab in Atopic Dermatitis
3
Mins
March 2025
Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…
Read more
9
Mins
11 Nov 2021
Emerging Treatment Regimens in Psoriasis: Are There Advantages Over Current Biologic Therapies?
Psoriasis is a chronic inflammatory skin condition that impacts patients’ quality of life and has large economic consequences…
10
Mins
22 Oct 2021
Patient-Reported Outcomes with Monoclonal Antibody Therapies in Patients with Moderate-to-Severe Plaque Psoriasis
Richard B. Warren highlighted Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the Phase III BE VIVID trial in patients…
10
Mins
20 Oct 2021
Efficacy and Safety of Monoclonal Antibody Therapies in Patients with Moderate-to-Severe Plaque Psoriasis
In the late-breaking research sessions, Reich presented BE RADIANT, the first Phase III trial to compare inhibition of IL-17A and IL-17F…
6
Mins
15 Oct 2021
Where Do We Begin? The Key Role of the IL-23 Pathway in Psoriasis and Psoriatic Arthritis
This Janssen-sponsored live satellite symposium, entitled ‘Where do we begin? The key role of the IL-23 pathway in psoriasis and psoriatic…
9
Mins
17 Jun 2021
Pioneering Best Practices in Atopic Dermatitis: Results from the Quality of Care Initiative
Pioneering global best practices in atopic dermatitis (AD) and implementing them in the clinic are important steps towards optimising patient care…
11
Mins
17 May 2021
Botulinum Toxins in Medical and Cosmetic Dermatology
Botulinum neurotoxins (BoNTs) are derived from Clostridium botulinum, a gram-positive anaerobe. While there are seven subtypes of BoNT (A to G), only A…
5
Mins
3 May 2021
Prominent Cutaneous Manifestation of COVID-19: A Case Report
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen and the subsequent coronavirus disease (COVID-19) mainly affect the lung…
10
Mins
29 Mar 2021
Advancing Breakthrough Innovative Treatment in Paediatric Dermatitis and Various Skin Disorders
Eczematous dermatitis (or eczema) includes AD, CD, and DD. This inflammatory skin reaction presents as erythema, vesicles, desquamation…
15
Mins
23 Mar 2021
The Treatment Landscape of Atopic Dermatitis: Interviews with Three Consultant Dermatologists
Atopic dermatitis (AD), sometimes referred to as ‘atopic eczema’, is a common, chronic, pruritic, Type II inflammatory skin disease which is associated…
12
Mins
23 Mar 2021
Transient Cutaneous Alterations of the Newborn
At birth, the skin of the newborn suddenly comes into contact with the extrauterine world: a dry and aerobic environment.1 Newborn skin is 40–60%…
14
Mins
15 Mar 2021
Syphilis Diagnosis and Treatment: State of The Art
Syphilis is a chronic bacterial infection caused by Treponema pallidum subspecies pallidum, known by clinicians for hundreds of years and with more than 5 million new cases diagnosed every year worldwide…
11
Mins
25 Feb 2021
Clinical Considerations Based On 5-Year Efficacy and Safety Data for the IL-23p19 Inhibitor Tildrakizumab
The indicative scaly, erythematous plaques of plaque psoriasis arise because of abnormal interactions between immune system cells and epidermal…
9
Mins
18 Feb 2021
Biological and Clinical Impacts of Ultraviolet-A on the Skin: New Insights
Terrestrial solar UVR consists of UVA (320–400 nm) and UVB (280–320 nm; typically around 295–320nm because of attenuation by the ozone…
11
Mins
10 Feb 2021
Long-term Efficacy and Safety of Tildrakizumab: 5-year Results from the reSURFACE 1 and 2 Phase III Trials in Patients with Moderate-to-severe Plaque Psoriasis
Psoriasis, a chronic systemic inflammatory disease with skin manifestations, can be an impediment to daily life. Accordingly…
8
Mins
15 Dec 2020
The Other Side of the Moon: A Clinical Dialogue on the IL-23 Pathway
Prof Reich began by highlighting how insights into the pathophysiology of psoriasis have led to the development and expansion of cytokine-targeted…
6
Mins
15 Dec 2020
Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from EADV 2020
The VOYAGE 1 trial1 was a placebo- and active-controlled Phase III study to evaluate long-term efficacy and safety of the IL-23p19 inhibitor guselkumab…
8
Mins
15 Dec 2020
Bimekizumab Efficacy and Safety in Patients with Moderate-to-Severe Plaque Psoriasis
Psoriasis is a Th17-driven disease, with both IL-17A and IL-17F playing a pivotal role in its pathogenesis.2,3 BKZ is a monoclonal IgG1 antibody…
9
Mins
15 Dec 2020
Editor’s Pick: Managing Chronic Urticaria: Quo Vadis?
Chronic urticaria (CU) is one of the most commonly diagnosed skin conditions. CU is characterised by the presence of recurrent wheals and/or angioedema…
8
Mins
15 Dec 2020
Impaired Mitochondrial and Metabolic Function of Fibroblasts Derived from Patients with Recessive Dystrophic and Junctional Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosa (RDEB) and junctional EB (JEB) are inherited disorders characterised by fragility and blistering of epithelial…
11
Mins
15 Dec 2020
Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
With the recent advancements of biologic therapies that block IL-23, there is increasing need for analysis of which biologics are most efficacious…
4
Mins
15 Dec 2020
Case Report: Suspected Case of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Overlap Due to Ursodeoxycholic Acid
Stevens–Johnson syndrome and toxic epidermal necrolysis are well-known severe cutaneous adverse reactions, with >100 medications previously implicated…
8
Mins
17 Aug 2020
Differential Diagnosis of Nail Psoriasis and Onychomycoses: A Report Based on 40 Years of Specialised Nail Consultations
Ungual psoriasis and onychomycosis are common nail diseases. Despite their different aetiology and course, surprisingly they have much in common.
6
Mins
31 Jul 2020
Clinical Cases in Dermatology: Modern Management of Acne, Actinic Keratosis, and Atopic Dermatitis
This clinical dermatology report examines six short case studies of patients diagnosed with acne vulgaris, actinic keratosis (AK), and atopic dermatitis (AD)…
6
Mins
23 Jun 2020
Chlormethine Gel for Mycosis Fungoides T-cell Lymphoma: Recent Real-World Data
An enhanced understanding of real-world CL Gel usage could help improve the management of patients with MF-CTCL…
10
Mins
23 Jun 2020
Managing Pemphigoid Gestationis
Pemphigoid gestationis (PG) is a rare pruritic autoimmune blistering skin disease associated with pregnancy and is classified as a pregnancy-specific…
12
Mins
28 May 2020
Holistic Assessment is Vital: Key Considerations in the Treatment of the Psychosocial Elements of Psoriasis
“Psoriasis isn’t just a skin disease”: depression, anxiety, and alexithymia are common in people living with the condition, as are low self-esteem…
9
Mins
14 May 2020
Highlights of the European Organisation for Research and Treatment of Cancer-Cutaneous Lymphoma Task Force (EORTC-CLTF) Annual Congress 2019 (Athens, Sept 26-28): Experiences with Chlormethine Gel in Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)
MF-CTCL is a rare type of cutaneous non-Hodgkin’s lymphoma where uncontrolled growth of the pathological skin-homing T-lymphocytes results first in skin…
10
Mins
11 May 2020
Photoprotection: Key Concepts, Current Status, and Special Patient Groups
Cumulative or excessive solar exposure is detrimental to skin health.1 Furthermore, certain population groups require extra care…
4
Mins
4 May 2020
Sebaceous Carcinoma: A Rare Extraocular Presentation of the Cheek
Sebaceous carcinoma is a rare and very aggressive malignant skin cancer of the sebaceous gland. While sebaceous glands are present all over the body…
10
Mins
31 Mar 2020
Editor's Pick: Chronic Spontaneous Urticaria: A Review of Pathological Mechanisms, Diagnosis, Clinical Management, and Treatment
Urticaria is a common mast cell-driven disease characterised by wheals and/or angioedema (), defined as chronic…
6
Mins
31 Mar 2020
Clinical Profile of Patients with Psoriasis and their Attitude Towards the Illness
Skin diseases such as psoriasis can profoundly influence a patient’s self-image, self-esteem, and sense of wellbeing. The chronic nature of the disease…
9
Mins
28 Feb 2020
Biologics in Moderate-to-Severe Psoriasis: Discover the Road to Long-term Control
Advances in the treatment of moderate-to-severe psoriasis have accelerated considerably in the last 30 years. Prof Piaserico provided an overview of the…
8
Mins
28 Feb 2020
Tildrakizumab in Patients with Moderate-to-Severe Psoriasis: Post-Hoc Analyses on Efficacy, Time to Relapse, Long-Term Safety in Elderly Population and Predictability From The reSURFACE 1 and reSURFACE 2 Phase III Clinical Trials
Psoriasis is a chronic, relapsing inflammatory skin disease, characterised in most cases by sharply demarcated, erythematous, pruritic plaques covered…
4
Mins
28 Feb 2020
Long-Term Safety of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis through 3 Years (148 Weeks) from reSURFACE 1 and reSURFACE 2 Phase III Trials
IL-23 plays a key regulatory role in the pathogenesis of plaque psoriasis and medications targeting IL-23 have been shown to be effective for people with…
10
Mins
10 Jan 2020
Treat Psoriasis: A New Era is Coming
Development of psoriasis occurs due to interactions with epidermal keratinocytes and immune-system cells including T-lymphocytes, antigen-presenting…
8
Mins
10 Jan 2020
New Insights into Dimethyl Fumarate, an Oral Therapy for the Treatment of Plaque Psoriasis
Psoriasis is associated with high morbidity, causing problems in daily life such as itching and scaling, even for patients with less-severe disease…
4
Mins
19 Dec 2019
Connecting the Dots Between Skin and Allergy
Allergies represent a significant, rising health concern. Recent figures indicate that 150 million Europeans experience chronic allergic disease…
6
Mins
12 Dec 2019
IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance
The symposium “IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance” took place during the 2019 annual European Academy of Dermatology…
10
Mins
12 Dec 2019
Latest Highlights from Guselkumab in Psoriasis from EADV 2019
Guselkumab was the first monoclonal antibody targeting the p19 subunit of IL-23 (IL-23p19) to be approved for the treatment of psoriasis.
10
Mins
12 Dec 2019
Management of Moderate-to-Severe Atopic Dermatitis in the Era of Targeted Treatments
Prof Augustin opened the symposium by underlining how the management of patients with moderate-to-severe atopic dermatitis (AD) has become more dynamic…
9
Mins
26 Nov 2019
Psoriasis and Atopic Dermatitis: Addressing Therapeutic Paradigms by Learning from Each Other
Psoriasis and AD are chronic, systemic inflammatory diseases of the skin characterised by upregulation of proinflammatory cytokines…
9
Mins
26 Nov 2019
Editor's Pick: Acne Therapy Across Time in the USA
Acne is the most common skin condition in the USA, affecting over half of its population.1 It is an inflammatory skin disease that predominantly…
10
Mins
26 Nov 2019
Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review
Atopic dermatitis (AD) is one of the most common and debilitating chronic inflammatory skin diseases, often greatly affecting physical, economical…
9
Mins
26 Nov 2019
Considering Tomorrow in Today’s Treatment Choice of Women Living with Psoriasis
The objectives of this symposium were to understand the importance of planning treatment addressing the specific needs of women living…
9
Mins
26 Nov 2019
Epithelial Barrier Dysfunction in Type 2 Inflammatory Diseases
Type 2 immunity evolved from a dialogue between the immune system and microbes. This form of immunity confers protection against bacteria, viruses…
3
Mins
26 Nov 2019
Near Circumferential Invasive Proliferative Gelatinous Mass in the Calf: An Unusual Presentation of Hidradenitis Suppurativa
Hidradenitis suppurativa, or acne inversa, is a chronic, recurrent inflammatory disease of the skin and subcutaneous tissue characterised by painful…
6
Mins
26 Nov 2019
Serum Sickness-Like Reaction in Children: Review of the Literature
The main objective of this manuscript is to offer an organised and updated review of the clinical features and current treatment options for paediatric serum sickness-like reaction.
7
Mins
26 Nov 2019
Rosacea: The Patient Experience is Now 'CLEAR'
Prof Schaller posed the question “what makes rosacea so special?” and explained that the manifestations of rosacea are very varied, including papules…
11
Mins
26 Nov 2019
IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Review of Clinical Efficacy, Safety, and Tolerability
Psoriasis is a common, chronic, immune-mediated skin disease affecting approximately 2–3% of the global population…
5
Mins
28 Oct 2019
Pathways to Silencing Psoriasis: Remission or Cure?
Psoriasis occurs more frequently alongside other IMID, indicating common pathogenetic pathways. Many of these IMID show familial accumulation…
4
Mins
18 Oct 2019
Advances and Latest Insights in Non-Biologic Systemic Therapeutic Agents in Psoriasis and Atopic Dermatitis
The fumarates, monoethyl fumarate (MEF) and dimethyl fumarate (DMF), are potent ester derivatives of fumaric acid. Fumaric acid esters (FAE)…
10
Mins
17 Sep 2019
IL-23 Inhibition in Psoriasis: A Novel Approach to Convenient, Consistent Clearance
This sponsored symposium took place on 12th June 2019 in Milan, Italy, as part of the 24th World Congress of Dermatology (WCD), 2019
9
Mins
16 Sep 2019
Spotlight on Acne
This symposium took place on 13th June 2019, as part of the World Congress of Dermatology (WCD) symposium in Milan, Italy
4
Mins
12 Sep 2019
Scalp Sarcoidosis with Systemic Involvement: A Case Report and Literature Review
Sarcoidosis is a multisystem disease, of unknown aetiology, which can involve any organ of the body, even if it more frequently affects the lymph nodes…
9
Mins
11 Sep 2019
IL-23 Inhibition as a Key Component in Psoriasis Treatment is Here to Stay
Prof Elke de Jong focussed her presentation on data from randomised clinical trials (RCT) and real-world evidence (RWE) from psoriasis patient registries.
10
Mins
20 Aug 2019
Right Treatment to the Right Patient in Moderate-to-Severe Psoriasis: Discussion on Difference
Dermatologists frequently see psoriasis patients for whom the most troublesome symptoms are not the constant physical discomfort…
10
Mins
13 Jun 2019
Chemokine Pathway Can Be the Potential Therapeutic Target for Hypertrophic Scar
Hypertrophic scar (HTS) is a dermal form of fibroproliferative disease that develops after deep burns, skin injuries, and surgical wounds. HTS is defined…
10
Mins
13 Jun 2019
After Conventional Wisdom Has Failed, What Drives Wound Healing?
The purpose of this paper is to explore heat shock protein 90-alpha (Hsp90α)’s role as a potential driver of wound healing and as a possible future…
10
Mins
14 Mar 2019
Discover the Potential: Exploring New Frontiers of IL-23 Inhibitors
Affecting up to 11.4% of the population worldwide, psoriasis is one of the most common chronic autoinflammatory diseases.
9
Mins
14 Mar 2019
Clinical Conditions that Masquerade as Urticaria
Chronic urticaria is one of the most commonly diagnosed dermatoses. Following diagnosis, correct identification and proper treatment significantly reduces disease activity, thereby improving the patient’s quality of life.
10
Mins
12 Feb 2019
Translating Evidence to Practice: From Clinical Research to Real-World Experience
The goal of this programme is to support dermatologists to improve the management of patients with moderate-to-severe AD and bring together clinicians…
5
Mins
7 Feb 2019
Dimethyl Fumarate in Psoriasis Therapy
This presentation by Dr Weisenseel considered the role of fumaric acid esters (FAE) in plaque psoriasis.
9
Mins
29 Jan 2019
Unlocking the Potential of Immuno-Oncology in Advanced Cutaneous Squamous Cell Carcinoma: Role of Checkpoint Blockade
The rising incidence of CSCC presents a major challenge for healthcare systems and the frequency and impact of progression to advanced disease is…
8
Mins
13 Dec 2018
Translating Knowledge of IL-23 Targeting into New Solutions for Psoriasis Treatment
Following a brief introduction by Prof Lambert, the symposium started with an in-depth review of the current unmet needs in the clinical management of…
9
Mins
13 Dec 2018
Chronic Spontaneous Urticaria in Patients with Common Variable Immunodeficiency
Common variable immunodeficiency (CVID) is a predominantly antibody deficiency and is one of the most common primary…
10
Mins
30 Oct 2018
PASI 90/100, DLQI 0/1, and IL-17 Receptor/Cytokine: Does it Make a Difference and Are We Ambitious Enough?
The main objectives of the symposium were to review recent evidence on what difference targeting Psoriasis Area Severity Index (PASI) 90 or 100 and…
9
Mins
30 Oct 2018
Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey
The importance of discussions around the management of women of childbearing age with psoriasis, an issue that has been largely neglected for many years…
10
Mins
30 Oct 2018
Is Complete Skin Clearance in Psoriasis the Answer?
Prof Reich outlined the new understanding of psoriasis pathogenesis, with IL-23 rather than IL-12 considered the pivotal cytokine pathway. This…
9
Mins
30 Oct 2018
IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future
This symposium took place at the 27th European Academy of Dermatology and Venereology (EADV) Congress. The session examined the latest data for…
9
Mins
30 Oct 2018
From Evolution to Revolution: IL-23 in the Treatment of Psoriasis Patients
This symposium, which took place during the 2018 meeting of the European Academy of Dermatology and Venereology (EADV) in Paris, France, provided…
10
Mins
30 Oct 2018
Emerging Insights in the Treatment of Psoriasis and Psoriatic Arthritis
Guselkumab is a monoclonal antibody targeting IL-23 that is approved for the treatment of patients with moderate-to-severe plaque psoriasis. Two of…
9
Mins
30 Oct 2018
Efficacy, Sustainability, and Patient-Reported Outcomes of Guselkumab to Treat Plaque Psoriasis in the Post-Approval Setting
Plaque psoriasis is an autoimmune condition characterised by the development of red, dry, scaly skin lesions that cause irritation and pain for patients…
10
Mins
30 Oct 2018
Editor’s Pick: Beneath the Skin: The Relationship Between Psychological Distress and the Immune System in Patients with Psoriasis
Psoriasis is a chronic autoimmune skin disease with significant physical and psychiatric comorbidities and affects 2–3% of people worldwide.
5
Mins
30 Oct 2018
A Systematic Review on the Efficacy of Topical Acyclovir, Penciclovir, and Docosanol for the Treatment of Herpes Simplex Labialis
The objective of this study was to conduct a systematic review of the available evidence on the treatment of herpes simplex labialis with U.S. Food and Drug Administration (FDA)-approved topical antibiotics.
8
Mins
30 Oct 2018
Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers
Chronic urticaria (CU) is characterised by intense recurrent itch, wheals, and/or angioedema, persisting for >6 weeks. CU can be subdivided into chronic…
10
Mins
30 Oct 2018
Lingual Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Successfully Treated with Adalimumab: A Rare Case Report and Review of Oral Psoriasis
Psoriasis is a common skin disease with various cutaneous manifestations and is classified into two clinical groups: non-pustular and pustular.
8
Mins
9 Aug 2018
The Changing Landscape of Psoriasis: New Horizons for Oral Therapies
Prof Boehncke opened the symposium and highlighted the changing landscape of psoriasis management. On behalf of Prof Mrowietz, who was unable to attend…
6
Mins
9 Aug 2018
Psoriasis: From Gene to Clinic
Substantial developments over the last decade have advanced our knowledge and understanding of psoriasis, from both a basic scientific and clinical…
10
Mins
21 Jun 2018
A Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2018
This article reviews new data presented at the recent European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2018. The role of topical…
8
Mins
7 Jun 2018
Treating Psoriasis: What Is New About Fumaric Acid Esters?
This publication covers the first session of Almirall’s 11th Skin Academy meeting in Barcelona, Spain. This year, the meeting theme was ‘The Science of…
4
Mins
6 Jun 2018
Psoriasis and Direct-to-Consumer Advertising: A Useful Tool in Reducing Stigma?
The beginning of warmer weather brings optimism for most people as they emerge from winter. However, for those of us living with a highly stigmatised…
4
Mins
2 Mar 2018
The Impact of Social Media on Psoriasis Care
Social media platforms, such as Instagram, are particularly powerful when it comes to empowering psoriasis patients and reducing social stigma.
8
Mins
1 Mar 2018
Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape
Prof Reich welcomed delegates to the satellite symposium and explained that the aims of the meeting were to introduce the clinical role of targeted…
9
Mins
1 Mar 2018
From Registry Data to Real-Life Experiences: A Holistic Perspective of Psoriasis Treatment
Registries provide very high-quality data on the persistence of different therapies in the real world and can be used to compare and guide therapeutic…
7
Mins
1 Mar 2018
Interleukin-23 Inhibition as a Strategy to Treat Immune-Mediated Inflammatory Diseases
The satellite symposium comprised two short presentations aimed at providing an overview of the rationale for the use of interleukin (IL)-23 inhibition…
8
Mins
1 Mar 2018
Psoriasis: Beyond the Skin
Previously considered as just a skin condition, psoriasis has come to be regarded as a complex, systemic inflammatory disorder that affects multiple…
9
Mins
1 Mar 2018
Urticaria Diagnosis
Urticaria is a common skin condition that, though rarely fatal, can seriously impair a patient’s quality of life. Urticaria is caused by…
6
Mins
1 Mar 2018
When the Nail Appearance Plays Tricks: A Case of Longitudinal Melanonychia
This article presents a case of longitudinal melanonychia in a teenager with atypical signs and a good prognosis.
3
Mins
25 Jan 2018
Preventing Disabilities in Children Caused by Leprosy
This year, World Leprosy Day falls on Sunday 28th January. The occasion has been observed since 1954 and aims to raise awareness, providing more people…
10
Mins
30 Nov 2017
Tackling the Inflammatory Burden of Psoriasis: A Multidisciplinary Approach
Prof Girolomoni provided an overview of psoriasis, considering how patients are frequently affected by other comorbidities.
8
Mins
30 Nov 2017
Developments in the Treatment and Management of Psoriasis
The oral session consisted of a talk on the 2-year efficacy and safety of guselkumab in the treatment of moderate-to-severe psoriasis from the Phase III VOYAGE 1 trial.
7
Mins
30 Nov 2017
Linking Pathophysiology to Clinical Options in Psoriasis: New Insights into Interleukin-23
Prof Costanzo welcomed attendees to the symposium and outlined the agenda before explaining the autoimmune pathophysiology that underlies psoriasis.
9
Mins
30 Nov 2017
Proteomic Analysis of Antiprotease Immunoglobulin-E Anti-Sperm Autoantibodies in Chronic Urticaria After Vasectomy
Some types of chronic urticaria (CU) are associated with autoreactive immunoglobulin (Ig)E, as well as IgG. In the syndrome of autoimmune thyroid disease…
3
Mins
7 Nov 2017
My Experience with Isotretinoin
MY TREATMENT with isotretinoin was a long time coming. Having suffered for many years with severe acne, and with antibiotics only making a small dent in…
10
Mins
2 Nov 2017
Innovation That Drives Your Dermatological Future
This symposium is focused on topical therapies in the treatment of psoriasis and the unmet clinical and patient quality of life needs.
9
Mins
2 Nov 2017
Advancing Science: Driving Progress Today for a Clearer Tomorrow
Dermatologists today have more tools than ever at their disposal for managing psoriasis, including newer-generation biologics, which target molecular…
1
Mins
2 Nov 2017
Special Poster Feature: Certolizumab Pegol: A Future Treatment Option for Patients Suffering from Psoriasis
Psoriasis is a chronic inflammatory disease that is associated with a reduction in quality of life (QoL) and professional work productivity.
10
Mins
2 Nov 2017
Editor’s Pick: Hidradenitis Suppurativa (Acne Inversa): A Review of Aetiopathogenesis and Management
Hidradenitis suppurativa is a debilitating, chronic, relapsing inflammatory condition associated with the development of painful nodules.
9
Mins
2 Nov 2017
Chronic Urticaria in Children: A Review
In children, chronic urticaria is substantially less common than acute urticaria but is associated with a larger decrease in quality of life. Read to find out more.
9
Mins
2 Nov 2017
Psychosocial Issues in Dermatology
Skin, with its many biological functions, has a unique aesthetic value and determines the self-image and psyche of the person in terms of how they think…
8
Mins
2 Nov 2017
Hidradenitis Suppurativa: A Retrospective Review of 13 Patients and Literature Summary
Hidradenitis suppurativa is an inflammatory skin condition of the follicular pilosebaceous unit that primarily affects flexural areas where apocrine…
8
Mins
2 Nov 2017
Dermoscopy of Inflammatory Conditions: The Journey So Far
The use of dermoscopy in general dermatological practice has recently increased.
6
Mins
2 Nov 2017
Chronic Urticarial Vasculitis and Immunoglobulin-G Monoclonal Gammopathy: Variant Schnitzler Syndrome
Schnitzler syndrome is a rare acquired autoinflammatory disorder that is characterised by recurrent fevers, bone or joint pains, urticarial rash, and…
9
Mins
2 Nov 2017
Mind–Body Integrative Treatment of Psychodermatoses
The mind–skin interaction has been progressively clarified by recent research that has focussed on psychoneuroimmunology.
3
Mins
9 Aug 2017
Spasmodic Dysphonia: What About It?
Spasmodic dysphonia (SD): what about it? That is the million-dollar question.
5
Mins
2 Mar 2017
Haemangioma: A Review of the Literature and an Unusual Case Report
Haemangiomas are benign tumours growing by vascular endothelial hyperplasia, commonly occurring in females.
21
Mins
13 Feb 2017
Insuficiencia venosa crónica: manejo y tratamiento
La EVC es una enfermedad preocupante que genera una carga significativa sobre los servicios sanitarios y la sociedad en general.
15
Mins
13 Feb 2017
Chronic Venous Insufficiency: Management and Treatment
CVD is a very concerning condition which creates a significant burden on healthcare provision and wider society. Varicose veins are often the first sign of CVD.
9
Mins
15 Nov 2016
Useful Photoprotection in Dermatological Practice
The main objectives of this symposium were to explore the effect of light on individuals with hyperpigmentation disorders and acne, present the latest…
8
Mins
15 Nov 2016
Will Biosimilars Change the Treatment Paradigm in Psoriasis?
Prof Augustin opened the meeting and reviewed the use of systemic treatments recommended for moderate-to-severe psoriasis. Data indicating a lack of…
4
Mins
15 Nov 2016
Quality of Care: The Challenges, The Solutions
Psoriatic arthritis (PsA) and hidradenitis suppurativa (HS) are both immune-mediated diseases with common cellular and cytokine pathways involved in…
10
Mins
15 Nov 2016
Value in Psoriasis Care: From Patients to Payers
The symposium explored new approaches to optimising the value of psoriasis management from the perspective of physicians, patients, and healthcare…
9
Mins
15 Nov 2016
Editor’s Pick: The Role of Toll-Like Receptors and Antimicrobial Peptides in the Pathogenesis of Acne Vulgaris
Acne vulgaris (AV) is a chronic inflammatory disease of the pilosebaceous unit. AV has a multifactorial pathogenesis with specific roles played by the…
9
Mins
15 Nov 2016
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Literature Review of Current Treatments
Stevens-Johnson syndrome and toxic epidermal necrolysis are among the most concerning drug reactions affecting adults and children. Although the overall…
7
Mins
15 Nov 2016
Significance of Diet and Oral Supplementation in Acne Vulgaris
Acne vulgaris is one of the most common skin diseases in the world. There are many factors involved in its pathogenesis. The dermatosis is characterised…
9
Mins
15 Nov 2016
Immunopathogenesis of Leprosy: A Model for T Cell Anergy
Leprosy is a model disease for understanding human immune responses underlying diseases caused by intracellular pathogens, as well as providing valuable…
10
Mins
15 Nov 2016
Reconstructive Options for Cutaneous Defects of the Nose: A Review
Background: The face is the most common site affected by skin cancer in the body and of the facial skin it is the nose that bears the brunt of the attack.
9
Mins
15 Nov 2016
The Main Neonatal Dermatological Findings: A Review
Background: The neonatal period is a phase of adaptation during which several skin conditions can develop. Most of these findings characterise the…
7
Mins
15 Nov 2016
Skin Manifestations Associated with Brucellosis
Brucellosis is a zoonotic infectious disease of worldwide distribution and is still endemic in some developing countries. Brucellosis is a systemic…
3
Mins
12 Jul 2016
A Call from a Patient to Openly Discuss Body Image in the Treatment of Type 1 Diabetes
Diabetes is a non-communicable disease (NCD) meaning that it often cannot be seen. After 20 years of living with Type 1 diabetes I am lucky to have no…
24 Nov 2015
Biologic Therapies: Clinical Practice in a Changing Environment
Biological therapies have been in use for treating psoriasis for a decade now, and they have greatly improved disease outcomes and quality of life…
24 Nov 2015
The Skin Microbiome in Patients with Acne Vulgaris
Changes in the composition of cutaneous microbial communities have been linked to several chronic inflammatory skin diseases, including acne.
24 Nov 2015
A Rejuvenation Therapy of Medical Needling and 3D-Matrixlift® is Safe and Improves the Elasticity of the Skin
The use of platelet-rich plasma and growth factors is emerging as an anti-ageing regimen for the skin.
24 Nov 2015
Acne and Systemic Diseases
Acne is a very common, multifactorial, complex, and chronic disease of the pilosebaceous unit that affects approximately 85% of adolescent patients and…
24 Nov 2015
Pyoderma Gangrenosum: A Mini-Review
Pyoderma gangrenosum (PG) is a rare, chronic neutrophilic dermatosis of unknown aetiology that usually presents with necrotising ulcers, although…
24 Nov 2015
Quality of Life Evaluation in Psoriasis Patients Starting a Biological Treatment: The Importance of a More Comprehensive Assessment of Disease Burden
Psoriasis is a chronic condition that has a significant negative impact on a patient’s quality of life (QoL).
24 Nov 2015
Staphylococcus Aureus and Atopic Dermatitis: Which Came First, the Chicken or the Egg?
Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease that affects up to 25% of children and 10% of adults.
24 Nov 2015
Nasal Volumetric Remodelling with the Aid of a New, Stabilised Hyaluronic Acid Dermal Filler
Dermal fillers around the nose have become particularly popular among patients due to the minimally invasive aspect of these corrections.
Loading posts...
« Previous
1
…
22
23
24
25
26
27
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View